Your Messages Inbox
Your Article Summary
See Latest ArticlesData from largest GOLD Stage II patient population treated with tiotropium highlight the benefits of earlier treatment of COPD
Boehringer Ingelheim, 08/31/09
A new analysis of the landmark UPLIFT trial, published today in the Lancet, shows that tiotropium administered to Chronic Obstructive Pulmonary Disease patients with moderate disease severity produced significant and sustained improvements in lung function for up to 4 years.1 This pre–specified subgroup analysis involved 2,739 patients – the largest group of early stage COPD patients treated with a long–acting anticholinergic in a randomised, placebo–controlled study.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09
Prognostic Factors in Idiopathic Pulmonary Fibrosis
The American Journal of the Medical Sciences, 12/17/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
CCHIT Appoints Officers
HealthDataManagement, 12/18/09
Article Search
Sponsor